Eversept Partners’s Qiagen QGEN Stock Holding History

Eversept Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66M	Sell	68,100 -408,200	-86%	-$15.2M	0.14%	86
2026 Q1	$19.1M	Buy	+476,300	New	+$22.5M	1.01%	26

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Eversept Partners's QGEN Position: Q2 2026 in Review

Eversept Partners sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 545,330 shares — an estimated $20.3M sold.

Eversept Partners first reported a position in QGEN in Q4 2018 and held it in 12 quarters. The position peaked at $31.5M in Q2 2021. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Eversept Partners reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Eversept Partners sold 545,330 Qiagen shares in Q2 2026, an estimated $20.3M.
Eversept Partners first reported a position in Qiagen in Q4 2018 and held it in 12 quarters.
Eversept Partners's Qiagen position peaked at $31.5M in Q2 2021.
337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.